Marizyme Stock Price on September 18, 2024
| MRZM Stock | USD 0.05 0.01 25.00% |
If you're considering investing in Marizyme OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Marizyme stands at 0.05, as last reported on the 30th of November, with the highest price reaching 0.05 and the lowest price hitting 0.05 during the day. Marizyme is out of control given 3 months investment horizon. Marizyme has Sharpe Ratio of 0.0986, which conveys that the firm had a 0.0986% return per unit of risk over the last 3 months. We were able to analyze twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.95% are justified by taking the suggested risk. Use Marizyme Downside Deviation of 33.55, risk adjusted performance of 0.1027, and Mean Deviation of 9.89 to evaluate company specific risk that cannot be diversified away.
Marizyme OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Marizyme |
Sharpe Ratio = 0.0986
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | MRZM | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 19.82 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.95 actual daily | 38 62% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Marizyme is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Marizyme by adding it to a well-diversified portfolio.
Related Headline
Aerovate Therapeutics Headline on 18th of September 2024
Disposition of 6387 shares by Gillies Hunter of Aerovate The... by MacroaxisInsider
Filed transaction by Aerovate Therapeutics Officer Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Marizyme Valuation on September 18, 2024
It is possible to determine the worth of Marizyme on a given historical date. On September 18, 2024 Marizyme was worth 0.04 at the beginning of the trading date compared to the closed value of 0.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Marizyme otc stock. Still, in general, we apply an absolute valuation method to find Marizyme's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Marizyme where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Marizyme's related companies.
| Open | High | Low | Close | Volume | |
| 0.04 | 0.04 | 0.04 | 0.04 | 1.00 | |
09/18/2024 | 0.04 | 0.04 | 0.04 | 0.04 | 1.00 |
| 0.04 | 0.04 | 0.04 | 0.04 | 1.00 |
| Backtest Marizyme | | | Marizyme History | | | Marizyme Valuation | Previous | Next |
Marizyme Trading Date Momentum on September 18, 2024
| On September 19 2024 Marizyme was traded for 0.04 at the closing time. The top price for the day was 0.04 and the lowest listed price was 0.04 . There was no trading activity during the period 1.0. Lack of trading volume on September 19, 2024 did not cause price change. The trading delta at closing time against the current closing price is 25.00% . |
Marizyme Fundamentals Correlations and Trends
By evaluating Marizyme's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Marizyme's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Marizyme financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Marizyme OTC Stock history
Marizyme investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Marizyme is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Marizyme will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Marizyme stock prices may prove useful in developing a viable investing in Marizyme
Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. Marizyme, Inc. was incorporated in 2007 and is based in Jupiter, Florida. Marizyme operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 11 people.
Marizyme OTC Stock Technical Analysis
Marizyme technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Marizyme Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Marizyme cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQB Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Marizyme November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Marizyme otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Marizyme shares will generate the highest return on investment. By undertsting and applying Marizyme otc stock market strength indicators, traders can identify Marizyme entry and exit signals to maximize returns
Marizyme Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Marizyme's price direction in advance. Along with the technical and fundamental analysis of Marizyme OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Marizyme to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1027 | |||
| Jensen Alpha | 2.77 | |||
| Total Risk Alpha | (0.96) | |||
| Sortino Ratio | 0.0726 | |||
| Treynor Ratio | (1.57) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Marizyme OTC Stock
Marizyme financial ratios help investors to determine whether Marizyme OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marizyme with respect to the benefits of owning Marizyme security.